ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Ferrovial to delist shares from Euronext Amsterdam

Spanish infrastructure group Ferrovial plans to remove its shares from trading on Euronext Amsterdam, citing low liquidity and cost efficiency.

PA
Priya Anand · Equities & Earnings Desk · 16 Aug 2026 · 1 min read
Share
Ferrovial to delist shares from Euronext Amsterdam

Spanish infrastructure giant Ferrovial said on Monday it would delist its shares from Euronext Amsterdam, citing low trading volumes and a strategic shift toward more efficient capital markets.

The company, which has a primary listing on Spain’s Bolsa de Madrid, will request the removal of its ordinary shares from Euronext Amsterdam’s regulated market. Ferrovial stated the move aims to streamline operations and reduce administrative costs associated with maintaining a secondary listing.

Ferrovial’s decision follows a broader trend among multinational companies to consolidate listings in fewer markets, particularly when secondary venues see minimal investor participation. The delisting is expected to take effect after regulatory approval and a formal announcement of the timeline.

A company spokesperson confirmed that Ferrovial’s shares will remain fully tradable on the Bolsa de Madrid, where the majority of its trading activity occurs. The move does not affect the company’s corporate structure or operational activities.

Ferrovial, which operates in transport, energy and construction sectors, did not provide financial details related to the delisting but emphasized that the decision was driven by operational efficiency rather than financial distress.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT